Skip to main content
Clinical Trials/NCT05904925
NCT05904925Not yet recruitingNot Applicable

Pilates Exercises for the Prevention of Musculoskeletal Complaints During Pregnancy: a Protocol of a Pilot Randomized Controlled Trial With Economic Evaluation

Universidade Cidade de Sao Paulo0 sites20 target enrollmentStarted: July 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Primary Endpoint
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results)

Study Overview

Brief Summary

The goal of this pilot randomized controlled trial with economic evaluation is to evaluate the viability of Pilates in the prevention of musculoskeletal complaints, throughout the entire gestational period, in pregnant women. The main question it aims to answer is if it is feasible to perform exercises during the entire gestational period to prevent musculoskeletal disorders. Participants will be assessed primarily for acceptability, suitability, feasibility, and fidelity, and secondarily for the occurrence of musculoskeletal complaint and the number of days from randomization on which this musculoskeletal complaint occurred, type of delivery and costs. Then, participants will be randomized into two groups: the usual care group, which will receive an educational booklet with information about the usual care during pregnancy, and the Pilates group, which will receive the same educational booklet and will participate in a specific Pilates exercise program for the gestational period, twice a week, throughout the pregnancy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • pregnant women of usual risk in the 12th gestational week (gestational age determined by the date of the last menstruation or by the ultrasound examination)
  • with medical clearance to practice physical activity

Exclusion Criteria

  • practice of other physical activity during pregnancy
  • any medical contraindications, such as diabetes and hypertension

Outcomes

Primary Outcomes

Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results)

Time Frame: From 7 to 15 days after delivery

The participant's perception of the treatment result being satisfactory

Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises)

Time Frame: From 7 to 15 days after delivery

Assesses whether the exercise program is suitable for the target audience or needs some adaptation

Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment

Time Frame: From 7 to 15 days after delivery

Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out

Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty)

Time Frame: From 7 to 15 days after delivery

Assesses the level of difficulty of the selected exercises

Secondary Outcomes

  • Number of days from randomization on which the musculoskeletal complaint occurred(24th gestational week, 36th gestational week, and from seven to 15 days after delivery)
  • Delivery mode (normal or caesarean section)(From 7 to 15 days after delivery)
  • Baby's birth weight(From 7 to 15 days after delivery)
  • Apgar score (0 to 10)(From 7 to 15 days after delivery)
  • Occurrence of musculoskeletal complaint(24th gestational week, 36th gestational week, and from seven to 15 days after delivery)
  • Pain measured using the Pain Numerical Rating Scale in the occurrence of musculoskeletal complaint(24th gestational week, 36th gestational week, and from 7 to 15 days after delivery)
  • Kinesiophobia measured using the Tampa Scale of Kinesiophobia in the occurrence of musculoskeletal complaint(24th gestational week, 36th gestational week, and from 7 to 15 days after delivery)
  • Disability measured using the Patient Specific Functional Scale in the occurrence of musculoskeletal complaint(24th gestational week, 36th gestational week, and from 7 to 15 days after delivery)
  • Costs (healthcare costs, patient and family costs, and lost productivity costs) measured using a questionnaire specially developed for this study(Baseline, 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery)

Investigators

Sponsor
Universidade Cidade de Sao Paulo
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Cristina Maria Nunes Cabral

Professor

Universidade Cidade de Sao Paulo

Similar Trials